Skip to content
Wednesday, November 11, 2026
ReelFinder

Zimbabwe Turns Down ‘One-Sided’ US Healthcare Assistance Agreement Due to Information Concerns

Medical aid image
The proposed American financial assistance was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a significant US health deal worth $367m (272 million pounds) spanning five years due to the United States' insistence on confidential biological samples.

This move came to light following a official document dated December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".

An official spokesperson has since stated that the US was seeking biological samples for research and commercial gain but refused to share the resulting advantages from any future medical innovations.

"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has urged further talks to find a agreement suitable to both sides so the country's vital HIV programme can continue.

Wider Implications

This development follows a similar case in Kenya, where a high court suspended a related deal with the US after concerns were raised about the safety of Kenyans' medical information.

Since returning to office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

The agency had overseen aid for the American government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance openness and accountability.

Based on reports, Sixteen nations in Africa have so far signed similar agreements, constituting more than $18.3bn of fresh investment.

Details of the Rejected Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via US-supported initiatives," Tremont commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".

"Our nation was requested to share its genetic material and health information for a long time, without any corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"Effectively, our nation would provide the basic resources for medical research with no assurance that the final treatments would be available to our citizens if a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures previously set up via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.

"This mechanism is designed to ensure that when a country contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We welcome further dialogue with our American counterparts on how subsequent co-operation might be structured in a way that respects the independence and interests of each country."

Health Experts Reaction

A leading public health body said it understood the government's concerns, but urged that negotiations should continue considering much of the nation's HIV programmes depended on external financing.

"If technical issues exist, including those relating to information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group commented.

This impasse underscores the continuing challenges between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.

By

Justin Taylor

A film enthusiast and critic with over a decade of experience in reviewing movies and curating streaming content.

ReelFinder

Type to search articles.